How Might Anti-Obesity Medication Look Like in the Future?

In this episode, leading experts Dr. Daniela Liśkiewicz and Dr. Juan Pablo Frías explore the rapidly evolving landscape of anti-obesity medications. From the rise of GLP-1-based therapies and oral treatments to next-generation multi-agonists, this discussion highlights how innovation is transforming obesity care. The conversation moves beyond weight loss alone, focusing on treatment quality, long-term weight maintenance, and patient-centred outcomes. The speakers also examine emerging therapeutic targets, the importance of preserving muscle mass, and the growing role of lifestyle interventions alongside pharmacotherapy. Looking ahead, they share insights into future directions, from resetting metabolic “set points” to improving global access to treatment.